Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Acorda Therapeutics, Inc. | President and CEO, Director | Common Stock | 150K | $97.3K | $0.65 | Mar 17, 2023 | Direct |
Acorda Therapeutics, Inc. | President and CEO, Director | Employee Stock Option (right to buy) | 169K | Mar 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ACOR | Acorda Therapeutics, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | President and CEO, Director |
ACOR | Acorda Therapeutics, Inc. | Mar 16, 2023 | 2 | $12.6K | 4 | Mar 20, 2023 | President and CEO, Director |
ACOR | ACORDA THERAPEUTICS INC | Mar 17, 2022 | 1 | -$3.89K | 4 | Mar 21, 2022 | President and CEO, Director |
ACOR | ACORDA THERAPEUTICS INC | Nov 12, 2021 | 1 | $0 | 4 | Nov 15, 2021 | President and CEO, Director |
ACOR | ACORDA THERAPEUTICS INC | Sep 3, 2021 | 1 | -$17.3K | 4 | Sep 8, 2021 | President and CEO, Director |